Financhill
Back

ITeos Therapeutics Quote, Financials, Valuation and Earnings

ITeos Therapeutics Price Quote

$8.99

ITeos Therapeutics Key Stats

Sell
22
ITeos Therapeutics (ITOS) is a Sell

Day range:
$8.88 - $9.15
52-week range:
$8.73 - $18.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.49%

Volume:
903.5K
Avg. volume:
906K
1-year change:
1.01%
Market cap:
$328.3M
Revenue:
$12.6M
EPS:
$-3

How Much Does ITeos Therapeutics Make?

Data Unavailable

Is ITeos Therapeutics Growing As A Company?

Data Unavailable

ITeos Therapeutics Stock Price Performance

What Is ITeos Therapeutics 52-Week High & Low?

ITeos Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy ITeos Therapeutics?

Is ITeos Therapeutics Cash Flow Positive?

  • What Is ITOS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$114M
  • What Is ITeos Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $122.7M
  • What Is ITeos Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $31M

ITeos Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    ITOS return on invested capital is -18.01%
  • What Is ITeos Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -15.76%
  • What Is ITOS Return On Equity?
    ROE is a measure of profitability and is -18.01%

ITeos Therapeutics Earnings Date & Stock Price

ITeos Therapeutics Competitors

ITeos Therapeutics Dividend Yield

ITeos Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 81.09%
Revenue: 0% 3400%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 34.83
Upside from Last Price: 287.47%

Major Shareholders

  • How many ITOS shares are owned by institutional investors?
    52.6M ITOS shares are owned by institutional investors
  • How many ITOS shares are owned by insiders?
    288.2K ITOS shares are owned by insiders